# BYND — local-model

## Metadata

ticker: BYND
arm: local-model
judge_prompt_version: v2
context_sha256: 716249a0f7ef4f1788d71cd7c5ef929d42f5365331f561efba247fd74d03b8de
local_model_served_name: qwen2.5-7b-instruct
local_model_dir: qwen2.5-7b-instruct
local_model_backend: openai
local_model_url: http://vllm.financial-agent.svc:8000
local_model_sampling: {"max_tokens": 512, "min_p": 0.0, "repetition_penalty": 1.1, "temperature": 0.1, "top_k": 20, "top_p": 0.8}

## Retrieved source context

STOCK DATA:
{
  "ticker": "BYND",
  "company_name": "Beyond Meat, Inc.",
  "current_price": 10.03,
  "currency": "USD",
  "market_cap": 172455456.0,
  "forward_pe": -0.96216565,
  "week_52_high": 230.7,
  "week_52_low": 9.81,
  "revenue": 258844992.0,
  "net_income": 258864992.0,
  "profit_margin": 1.15852,
  "sector": "Consumer Defensive",
  "industry": "Packaged Foods"
}

NEWS ARTICLES:
[]

SEC FILING SUMMARIES:
{
  "10-K": {
    "form_type": "10-K",
    "filing_date": "2026-04-09",
    "summary": "ITEM 1A. RISK FACTORS. Risk Factor Summary We are providing the following summary of the risk factors to enhance the readability and accessibility of our risk factor disclosures. We encourage you to carefully review the full risk factors immediately following this summary as well as the other information in this report, including Item 7 , Management\u2019s Discussion and Analysis of Financial Condition and Results of Operations , Note Regarding Forward-Looking Statements , and our consolidated financial statements and related notes, before deciding whether to invest in shares of our common stock. The risks and uncertainties described in this report may not be the only ones we face. If any of the risks actually occurs, our business, financial condition, operating results, cash flows and prospect"
  },
  "10-Q": {
    "form_type": "10-Q",
    "filing_date": "2026-08-06",
    "summary": "ITEM 1A. RISK FACTORS. In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, Item 1A, Risk Factors, in our 2025 10-K, as updated and supplemented below and in our subsequent filings. These risks could materially harm our business, operating results and financial condition. Additional factors and uncertainties not currently known to us or that we currently consider immaterial also may materially adversely affect our business, financial condition or future results. Risk Factors Risks Related to Our Business Our strategic repositioning to \u201cBeyond The Plant Protein Company\u201d may not be successful, and our failure to effectively execute or realize the anticipated benefits of this strategy could have a material adverse effect"
  }
}

RAG — SEC HIGHLIGHTS:
[From Pinecone cache] I cannot provide a summary of the latest 10-K and 10-Q based on the information provided. The context only contains risk factor disclosures from a filing, which represent just one section of these comprehensive documents.

To properly summarize the key takeaways from a 10-K or 10-Q, I would need access to additional critical sections such as:

- Management's Discussion and Analysis (MD&A) of Financial Condition and Results of Operations
- Consolidated financial statements and balance sheets
- Cash flow statements
- Income statements
- Business overview and strategy
- Results of operations and performance metrics
- Liquidity and capital resources analysis

The risk factors alone do not provide sufficient information to characterize the company's overall financial performance, strategic direction, operational results, or financial condition. To obtain a complete understanding of the company's latest filings, you would need to review the full 10-K or 10-Q documents directly.

RAG — RISK FACTORS:
[From Pinecone cache] # Primary Risk Factors Disclosed

The company discloses risk factors across three main categories:

## Risks Related to Business Operations
- Adverse economic and political conditions, including inflation concerns, government shutdowns, and trade policy uncertainties
- History of losses and negative cash flows, with challenges in achieving sustained profitability
- Weakness in the plant-based meat category with ongoing demand declines
- Operational challenges including cost-reduction initiatives, workforce reductions, and leadership changes
- Ability to forecast demand and manage inventory effectively
- Supply chain disruptions and reliance on limited suppliers and distributors
- Customer consolidation and potential loss of significant customers
- Manufacturing facility disruptions and co-manufacturer dependencies
- Revenue growth challenges and seasonal fluctuations
- Talent retention and workforce management issues
- Integration risks from acquisitions and investments

## Risks Related to Products
- Food safety incidents and product misbranding concerns
- Declining sales of flagship products
- Changing consumer preferences and trends
- Challenges in introducing new products or improving existing ones
- Price volatility and ingredient/packaging cost fluctuations

## Risks Related to Industry and Brand
- Increased competition and new market entrants
- Industry consolidation pressures
- Brand reputation damage from quality or health issues
- Challenges in brand development and maintenance

Additionally, the company highlights geopolitical risks, including impacts from international conflicts, tariff uncertainties, and trade restrictions that could affect supply chains, pricing, and demand for products.

## Pre-written sections (judge input)

### Financial Health

Beyond Meat, Inc. (BYND) currently trades at $10.03 per share, with a market capitalization of approximately $172.46 million. The company's forward P/E ratio is negative (-0.96), indicating potential earnings growth expectations. Revenue stands at $258.84 million, while the net income is reported as $258.86 million, reflecting a profit margin of 1.16%. Despite these figures, investors should note the significant risks highlighted in recent SEC filings, which suggest potential challenges in executing strategic initiatives.

### Recent Developments

Beyond Meat's most recent SEC filings reveal significant strategic repositioning challenges, with the company's 2026 10-Q highlighting risks related to its shift toward becoming "Beyond The Plant Protein Company." The company's financial metrics show concerning trends, including a negative forward P/E ratio and a dramatic stock decline from a 52-week high of $230.70 to $10.03, reflecting substantial investor skepticism about execution and market viability. With a market cap of approximately $172 million and minimal profitability despite $259 million in revenue, Beyond Meat faces critical pressure to successfully execute its strategic repositioning while managing operational efficiency. Investors should closely monitor upcoming earnings reports and management commentary on the company's ability to stabilize margins and achieve its stated strategic objectives, as execution risk remains elevated.

### SEC Filing Highlights

Unable to provide accurate SEC filing highlights at this time. The available data contains only risk factor disclosures and lacks critical sections necessary for a comprehensive summary, including Management's Discussion and Analysis (MD&A), consolidated financial statements, income statements, and cash flow data. To generate meaningful takeaways on Beyond Meat's financial performance, operational results, and strategic direction, access to the complete 10-K or 10-Q filing is required. Please consult the full SEC filing documents directly for current financial and operational insights.

### Risk Factors

- **Operational Challenges:** Involves cost-reduction initiatives, workforce reductions, and leadership changes, which can impact operational efficiency and employee morale.
- **Supply Chain Disruptions:** Reliance on limited suppliers and distributors exposes the company to potential disruptions that can affect production and delivery schedules.

## Audited (Exec Summary + Outlook)

### Executive Summary
Beyond Meat is a plant-based protein company currently undergoing a significant strategic repositioning toward becoming "Beyond The Plant Protein Company," generating $258.84 million in revenue against a market capitalization of approximately $172.46 million. The stock is notable now because of a dramatic decline from a 52-week high of $230.70 to $10.03, reflecting deep investor skepticism about whether management can translate its repositioning narrative into durable profitability. The single most important near-term variable is whether Beyond Meat can demonstrate credible execution of its strategic shift — as evidenced in upcoming earnings reports and management commentary on margin stabilization — without which the current valuation offers little basis for renewed confidence.

### Outlook
The directional lean on Beyond Meat is **cautious**. The headwinds are substantial: a negative forward P/E ratio, a stock price that has fallen precipitously from its 52-week high, ongoing operational restructuring including workforce reductions and leadership changes, and a supply chain vulnerable to disruption given reliance on a limited supplier and distributor base. The strategic repositioning toward a broader plant-protein identity introduces additional execution risk, as brand transitions of this nature require sustained investment and consumer adoption at a time when the company's financial flexibility appears constrained. On the tailwind side, any meaningful evidence of margin stabilization, successful cost-reduction outcomes, or early signs of consumer traction under the repositioned brand could begin to shift sentiment. Investors should watch the following key variables closely: management's commentary on the pace and cost of the strategic transition, trends in gross and operating margins across upcoming earnings reports, any changes to the supplier and distributor base that could signal supply chain stabilization or further disruption, and the stability of the leadership team through the repositioning period. The cautious view would strengthen if execution evidence accumulates — stabilizing margins, coherent strategic messaging, and operational efficiency gains — and would weaken further if upcoming filings reveal continued margin pressure, accelerating cash consumption, or additional leadership instability.

---
*This brief is for informational purposes only and does not constitute financial advice.*

## Judge findings

I will now systematically audit every specific quantitative figure, price target, threshold, ratio, metric, percentage, named product milestone, or forward-looking number in the **Executive Summary** and **Outlook** sections.

---

## EXECUTIVE SUMMARY

---

CLAIM: "generating $258.84 million in revenue"
LABEL: SUPPORTED
REASON: The raw source data lists revenue as $258,844,992.00, which rounds to $258.84 million; the pre-written Financial Health section also states "Revenue stands at $258.84 million."

---

CLAIM: "market capitalization of approximately $172.46 million"
LABEL: SUPPORTED
REASON: The raw source data lists market_cap as $172,455,456.00, which rounds to approximately $172.46 million; confirmed in the pre-written Financial Health section.

---

CLAIM: "a dramatic decline from a 52-week high of $230.70"
LABEL: SUPPORTED
REASON: The raw source data explicitly lists week_52_high as 230.7; the pre-written Recent Developments section also states "$230.70."

---

CLAIM: "to $10.03"
LABEL: SUPPORTED
REASON: The raw source data lists current_price as 10.03; confirmed in the pre-written Financial Health section.

---

## OUTLOOK

---

CLAIM: "a negative forward P/E ratio"
LABEL: SUPPORTED
REASON: The raw source data lists forward_pe as -0.96216565, which is negative; confirmed in the pre-written Financial Health section.

---

CLAIM: "a stock price that has fallen precipitously from its 52-week high"
LABEL: SUPPORTED
REASON: Arithmetic check: current price $10.03 vs. 52-week high $230.70 — the stock is trading at approximately 4.3% of its 52-week high, confirming a precipitous decline; both figures are present in the source data.

---

CLAIM: "ongoing operational restructuring including workforce reductions and leadership changes"
LABEL: SUPPORTED
REASON: The RAG Risk Factors section explicitly lists "cost-reduction initiatives, workforce reductions, and leadership changes" as disclosed operational challenges, and the pre-written Risk Factors section repeats this.

---

CLAIM: "a supply chain vulnerable to disruption given reliance on a limited supplier and distributor base"
LABEL: SUPPORTED
REASON: The RAG Risk Factors section explicitly states "Reliance on limited suppliers and distributors exposes the company to potential disruptions," confirmed in the pre-written Risk Factors section.

---

CLAIM: "The strategic repositioning toward a broader plant-protein identity"
LABEL: SUPPORTED
REASON: The 10-Q SEC filing summary explicitly references the company's "strategic repositioning to 'Beyond The Plant Protein Company,'" confirmed in the pre-written Recent Developments section.

---

*No additional specific quantitative figures, price targets, thresholds, ratios, named product milestones, or forward-looking numbers appear in the Outlook section beyond those audited above. All directional and qualitative statements (e.g., "cautious," "financial flexibility appears constrained," "sustained investment") are non-quantitative and therefore outside the scope of this audit.*
